{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:51:24Z","timestamp":1794012684717,"version":"4.8.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["2019R1C1C1009875"],"award-info":[{"award-number":["2019R1C1C1009875"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s00415-022-11485-1","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T16:03:51Z","timestamp":1668614631000},"page":"1457-1465","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Anti-titin antibodies are associated with myocarditis in patients with myasthenia gravis"],"prefix":"10.1007","volume":"270","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5443-386X","authenticated-orcid":false,"given":"Sohyeon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6428-061X","authenticated-orcid":false,"given":"Ki Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5967-4830","authenticated-orcid":false,"given":"Hye Yoon","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4165-8901","authenticated-orcid":false,"given":"Hyung Jun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5525-6861","authenticated-orcid":false,"given":"Young-Chul","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4408-8265","authenticated-orcid":false,"given":"Ha Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5621-0811","authenticated-orcid":false,"given":"Seung Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,16]]},"reference":[{"key":"11485_CR1","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.hjc.2017.01.024","volume":"57","author":"E Giallafos","year":"2016","unstructured":"Giallafos E, Zouvelou V, Maurogeni S, Stamboulis E (2016) Subclinical cardiac involvement in thymomatous Myasthenia Gravis. Hellenic J Cardiol 57:345\u2013347","journal-title":"Hellenic J Cardiol"},{"key":"11485_CR2","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1001\/archneurol.2009.229","volume":"66","author":"S Suzuki","year":"2009","unstructured":"Suzuki S, Utsugisawa K, Yoshikawa H, Motomura M, Matsubara S, Yokoyama K et al (2009) Autoimmune targets of heart and skeletal muscles in myasthenia gravis. Arch Neurol 66:1334\u20131338","journal-title":"Arch Neurol"},{"key":"11485_CR3","first-page":"179","volume":"47","author":"C C\u0103lin","year":"2009","unstructured":"C\u0103lin C, Savu O, Dumitru D, Ghiorghiu I, C\u0103lin A, Capraru C et al (2009) Cardiac involvement in myasthenia gravis\u2013is there a specific pattern? Rom J Intern Med 47:179\u2013189","journal-title":"Rom J Intern Med"},{"key":"11485_CR4","doi-asserted-by":"crossref","unstructured":"Fogg R, Flashner L, Marte WJ, Choudry R, Undavia A, Prabhu A. Myasthenia Gravis, Myocarditis, and Pericarditis in a Patient with Thymoma (4122). AAN Enterprises; 2020.","DOI":"10.17161\/rrnmf.v2i3.14790"},{"key":"11485_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40792-021-01309-1","volume":"7","author":"C Furuta","year":"2021","unstructured":"Furuta C, Yano M, Numanami H, Yamaji M, Taguchi R, Haniuda M (2021) A case of thymoma-associated multiorgan autoimmunity including polymyositis and myocarditis. Surgical Case Reports 7:1\u20135","journal-title":"Surgical Case Reports"},{"key":"11485_CR6","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/jnen\/nly041","volume":"77","author":"DS Priemer","year":"2018","unstructured":"Priemer DS, Davidson DD, Loehrer PJ, Badve SS (2018) Giant cell polymyositis and myocarditis in a patient with thymoma and myasthenia gravis: a postviral autoimmune process? J Neuropathol Exp Neurol 77:661\u2013664","journal-title":"J Neuropathol Exp Neurol"},{"key":"11485_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/rcr2.6","volume":"1","author":"N Saito","year":"2013","unstructured":"Saito N, Shimizu K, Kawaishi M, Araya J, Nakayama K, Kuwano K (2013) A survival case of invasive thymoma accompanied by acute fulminant myocarditis. Respirology Case Reports 1:36\u201338","journal-title":"Respirology Case Reports"},{"key":"11485_CR8","doi-asserted-by":"publisher","first-page":"7571","DOI":"10.21037\/jtd-2019-thym-10","volume":"12","author":"TG Blum","year":"2020","unstructured":"Blum TG, Misch D, Kollmeier J, Thiel S, Bauer TT (2020) Autoimmune disorders and paraneoplastic syndromes in thymoma. J Thorac Dis 12:7571","journal-title":"J Thorac Dis"},{"issue":"306\u201314","key":"11485_CR9","volume":"160","author":"J Zhao","year":"2020","unstructured":"Zhao J, Bhatnagar V, Ding L, Atay SM, David EA, McFadden PM et al (2020) A systematic review of paraneoplastic syndromes associated with thymoma: Treatment modalities, recurrence, and outcomes in resected cases. J Thorac Cardiovasc Surg 160(306\u201314):e14","journal-title":"J Thorac Cardiovasc Surg"},{"key":"11485_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/00131402-200306000-00006","volume":"4","author":"M Guglin","year":"2003","unstructured":"Guglin M, Campellone JV, Heintz K, Parrillo JE (2003) Cardiac disease in myasthenia gravis: a literature review. J Clin Neuromuscul Dis 4:199\u2013203","journal-title":"J Clin Neuromuscul Dis"},{"key":"11485_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ijcme.2014.08.003","volume":"5","author":"P Shivamurthy","year":"2014","unstructured":"Shivamurthy P, Parker MW (2014) Cardiac manifestations of myasthenia gravis: a systematic review. IJC Metabolic & Endocrine 5:3\u20136","journal-title":"IJC Metabolic & Endocrine"},{"key":"11485_CR12","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/cen3.12611","volume":"11","author":"S Suzuki","year":"2020","unstructured":"Suzuki S, Nagane Y, Uzawa A, Imai T, Murai H, Nakahara J et al (2020) Anti-striational antibodies: Expanding their clinical significance. Clinical and Experimental Neuroimmunology 11:218\u2013224","journal-title":"Clinical and Experimental Neuroimmunology"},{"key":"11485_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3109\/08916939509001933","volume":"20","author":"G Skeie","year":"1995","unstructured":"Skeie G, Mygland A, Aarli J, Gilhus N (1995) Titin antibodies in patients with late onset myasthenia gravis: clinical correlations. Autoimmunity 20:99\u2013104","journal-title":"Autoimmunity"},{"key":"11485_CR14","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1001\/archneur.58.6.885","volume":"58","author":"AM Yamamoto","year":"2001","unstructured":"Yamamoto AM, Gajdos P, Eymard B, Tranchant C, Warter J-M, Gomez L et al (2001) Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients. Arch Neurol 58:885\u2013890","journal-title":"Arch Neurol"},{"key":"11485_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-41730-z","volume":"9","author":"K Kufukihara","year":"2019","unstructured":"Kufukihara K, Watanabe Y, Inagaki T, Takamatsu K, Nakane S, Nakahara J et al (2019) Cytometric cell-based assays for anti-striational antibodies in myasthenia gravis with myositis and\/or myocarditis. Sci Rep 9:1\u201310","journal-title":"Sci Rep"},{"key":"11485_CR16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1586\/14737175.9.3.351","volume":"9","author":"NE Gilhus","year":"2009","unstructured":"Gilhus NE (2009) Autoimmune myasthenia gravis. Expert Rev Neurother 9:351\u2013358","journal-title":"Expert Rev Neurother"},{"key":"11485_CR17","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","volume":"14","author":"NE Gilhus","year":"2015","unstructured":"Gilhus NE, Verschuuren JJ (2015) Myasthenia gravis: subgroup classification and therapeutic strategies. The Lancet Neurology 14:1023\u20131036","journal-title":"The Lancet Neurology"},{"key":"11485_CR18","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","volume":"87","author":"DB Sanders","year":"2016","unstructured":"Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I et al (2016) International consensus guidance for management of myasthenia gravis. Neurology 87:419","journal-title":"Neurology"},{"key":"11485_CR19","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","volume":"34","author":"AL Caforio","year":"2013","unstructured":"Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB et al (2013) Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 34:2636\u20132648","journal-title":"Eur Heart J"},{"key":"11485_CR20","doi-asserted-by":"crossref","unstructured":"Suzuki S, Baba A, Kaida K, Utsugisawa K, Kita Y, Tsugawa J, et al. Cardiac involvements in myasthenia gravis associated with anti\u2010K v1. 4 antibodies. European journal of neurology. 2014;21:223\u201330.","DOI":"10.1111\/ene.12234"},{"key":"11485_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117103","volume":"418","author":"V Oliveira","year":"2020","unstructured":"Oliveira V, Videira G, Sam\u00f5es R, Carneiro P, Neves E, Santos E (2020) Paraneoplastic neurological syndromes with onconeural antibodies: A single center retrospective study. J Neurol Sci 418:117103","journal-title":"J Neurol Sci"},{"key":"11485_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.607773","volume":"12","author":"A Swayne","year":"2021","unstructured":"Swayne A, Warren N, Prain K, Gillis D, O\u2019Gorman C, Tsang BK et al (2021) An Australian state-based cohort study of autoimmune encephalitis cases detailing clinical presentation, investigation results, and response to therapy. Front Neurol 12:607773","journal-title":"Front Neurol"},{"key":"11485_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2242","volume":"11","author":"W Cheng","year":"2021","unstructured":"Cheng W, Sun T, Liu C, Zhou Z, Duan J, Zhao Y et al (2021) A systematic review of myasthenia gravis complicated with myocarditis. Brain and Behavior 11:e2242","journal-title":"Brain and Behavior"},{"key":"11485_CR24","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1440-1789.2012.01345.x","volume":"33","author":"T Kon","year":"2013","unstructured":"Kon T, Mori F, Tanji K, Miki Y, Kimura T, Wakabayashi K (2013) Giant cell polymyositis and myocarditis associated with myasthenia gravis and thymoma. Neuropathology 33:281\u2013287","journal-title":"Neuropathology"},{"key":"11485_CR25","first-page":"30","volume":"53","author":"N Tanahashi","year":"2004","unstructured":"Tanahashi N, Sato H, Nogawa S, Satoh T, Kawamura M, Shimoda M (2004) A case report of giant cell myocarditis and myositis observed during the clinical course of invasive thymoma associated with myasthenia gravis. Keio J Med 53:30\u201342","journal-title":"Keio J Med"},{"key":"11485_CR26","doi-asserted-by":"crossref","unstructured":"Mavrogeni S, Ntoskas T, Gialafos E, Karabela G, Krommida M, Gatzonis S, et al. Silent myocarditis in myasthenia gravis. Role of cardiovascular magnetic resonance imaging. International journal of cardiology. 2016;202:629\u201330.","DOI":"10.1016\/j.ijcard.2015.09.055"},{"key":"11485_CR27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1046\/j.1365-3083.1998.00260.x","volume":"47","author":"G Skeie","year":"1998","unstructured":"Skeie G, Bentsen P, Freiburg A, Aarli J, Gilhus N (1998) Cell-mediated immune response against titin in myasthenia gravis: evidence for the involvement of Th1 and Th2 cells. Scand J Immunol 47:76\u201381","journal-title":"Scand J Immunol"},{"key":"11485_CR28","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0165-5728(00)00394-5","volume":"111","author":"F Romi","year":"2000","unstructured":"Romi F, Skeie GO, Vedeler C, Aarli JA, Zorzato F, Gilhus NE (2000) Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis: a study of IgG subclasses and clinical correlations. J Neuroimmunol 111:169\u2013176","journal-title":"J Neuroimmunol"},{"key":"11485_CR29","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.athoracsur.2009.07.047","volume":"89","author":"A Fayssoil","year":"2010","unstructured":"Fayssoil A, Nardi O, Orlikowski D, Combes A, Chastre J, Annane D (2010) Percutaneous extracorporeal membrane oxygenation for cardiogenic shock due to acute fulminant myocarditis. Ann Thorac Surg 89:614\u2013616","journal-title":"Ann Thorac Surg"},{"key":"11485_CR30","doi-asserted-by":"crossref","unstructured":"Fogg R, Flashner L, Marte W, Choudry R, Undavia A, Prabhu A. Myasthenia Gravis and Pericarditis in a Patient with Thymoma: Myasthenia Gravis and Pericarditis. RRNMF Neuromuscular Journal. 2021;2.","DOI":"10.17161\/rrnmf.v2i3.14790"},{"key":"11485_CR31","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/j.amjmed.2016.01.020","volume":"129","author":"K Limaye","year":"2016","unstructured":"Limaye K, Vallurupalli S, Lee RW (2016) Myasthenia of the Heart. Am J Med 129:e19\u2013e21","journal-title":"Am J Med"},{"key":"11485_CR32","doi-asserted-by":"crossref","unstructured":"Xing Q, Zhang Z-W, Lin Q-H, Shen L-H, Wang P-M, Zhang S, et al. Myositis-myasthenia gravis overlap syndrome complicated with myasthenia crisis and myocarditis associated with anti-programmed cell death-1 (sintilimab) therapy for lung adenocarcinoma. Annals of Translational Medicine. 2020;8.","DOI":"10.21037\/atm.2020.01.79"},{"key":"11485_CR33","doi-asserted-by":"crossref","unstructured":"Kim KH, Kim SW, Cho J, Chung HY, Shin HY. Anti-titin antibody is associated with more frequent hospitalization to manage thymoma-associated myasthenia gravis. Frontiers in Neurology. 2022;13.","DOI":"10.3389\/fneur.2022.978997"},{"key":"11485_CR34","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1001\/archneur.57.11.1596","volume":"57","author":"F Romi","year":"2000","unstructured":"Romi F, Skeie GO, Aarli JA, Gilhus NE (2000) The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies. Arch Neurol 57:1596\u20131600","journal-title":"Arch Neurol"},{"key":"11485_CR35","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3389\/fimmu.2020.00212","volume":"11","author":"K Lazaridis","year":"2020","unstructured":"Lazaridis K, Tzartos SJ (2020) Autoantibody specificities in myasthenia gravis; implications for improved diagnostics and therapeutics. Front Immunol 11:212","journal-title":"Front Immunol"},{"key":"11485_CR36","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1001\/archneur.62.3.442","volume":"62","author":"F Romi","year":"2005","unstructured":"Romi F, Skeie GO, Gilhus NE, Aarli JA (2005) Striational antibodies in myasthenia gravis: reactivity and possible clinical significance. Arch Neurol 62:442\u2013446","journal-title":"Arch Neurol"},{"key":"11485_CR37","doi-asserted-by":"crossref","unstructured":"Sugiyama Y, Esa Y, Watanabe A, Kobayashi J, Suzuki S, Takahashi D. Immune checkpoint inhibitor-induced anti-striational antibodies in myasthenia gravis and myositis: a case report. Rinsho Shinkeigaku= Clinical Neurology. 2021.","DOI":"10.5692\/clinicalneurol.cn-001604"},{"key":"11485_CR38","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3389\/fneur.2019.00770","volume":"10","author":"Z Zhou","year":"2019","unstructured":"Zhou Z, Chen X, Liu G, Pu J, Wu J (2019) Presence of multiple autoimmune antibodies involved in concurrent myositis and myocarditis and myasthenia gravis without thymoma: a case report. Front Neurol 10:770","journal-title":"Front Neurol"},{"key":"11485_CR39","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1007\/s00415-004-0479-z","volume":"251","author":"XJ Chen","year":"2004","unstructured":"Chen XJ, Qiao J, Xiao BG, Lu CZ (2004) The significance of titin antibodiesin myasthenia gravis. J Neurol 251:1006\u20131011","journal-title":"J Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11485-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11485-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11485-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T13:05:02Z","timestamp":1677503102000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11485-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,16]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["11485"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11485-1","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,16]]},"assertion":[{"value":"22 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was conducted in accordance with the ethical standards of the institutional and national research committee and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was approved by the Institutional Review Board of Severance Hospital (IRB No.4\u20132021-0745).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"Informed consent was waived by our institutional ethical board because the research involves no more than minimal risk to participants and does not adversely affect their rights and welfare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}